罗库溴铵剂量与危重患者首次插管成功率:两项多中心试验的二次分析
该研究为两项多中心随机对照试验的二次分析,纳入美国9个急诊科和24个ICU中接受罗库溴铵紧急插管的1822例成人患者(占试验数据集的74.7%)。比较 high-dose(>1.2 mg/kg)与标准剂量(≤1.2 mg/kg)罗库溴铵,主要终点为首次插管成功。高剂量组720例(39.5%),标准剂量组1102例(60.5%);高剂量组首次插管成功率较高(调整RR 1.07,95%CI 1.02-1.12)。按场所分层后,该差异在急诊科插管中不存在(调整RR 0.97,95%CI 0.89-1.04),而在ICU插管中存在(调整RR 1.13,95%CI 1.06-1.20)。作者认为,鉴于可能存在未测量的混杂因素,这些发现需要在随机对照试验中评估。
要点
- 在ICU紧急插管的成人中,高剂量罗库溴铵(>1.2 mg/kg)与首次插管成功率较高相关(调整RR 1.13,95%CI 1.06-1.20)。
- 在急诊科紧急插管的成人中,高剂量与标准剂量罗库溴铵的首次插管成功率无显著差异(调整RR 0.97,95%CI 0.89-1.04)。
- 总体人群中,高剂量罗库溴铵与首次插管成功率较高相关(调整RR 1.07,95%CI 1.02-1.12)。
- 该分析纳入1822例接受罗库溴铵的患者,其中720例(39.5%)接受高剂量(>1.2 mg/kg),1102例(60.5%)接受标准剂量(≤1.2 mg/kg)。
- 作者认为,鉴于可能存在未测量的混杂因素,这些发现需要在随机对照试验中评估。
适用人群与场景
- 在美国9个急诊科和24个ICU中接受紧急气管插管的成人患者。
- 纳入两项多中心随机对照试验数据集中接受罗库溴铵的患者1822例(占2440例的74.7%)。
诊断标准与关键阈值
- 高剂量罗库溴铵定义为>1.2 mg/kg。
- 标准剂量罗库溴铵定义为≤1.2 mg/kg。
研究设计与关键结果
- 研究类型:两项多中心随机对照试验的二次分析,纳入美国9个急诊科和24个ICU的1822例接受罗库溴铵紧急插管的成人患者。
- 分组:高剂量罗库溴铵(>1.2 mg/kg)720例(39.5%) vs 标准剂量罗库溴铵(≤1.2 mg/kg)1102例(60.5%)。
- 主要终点:高剂量组首次插管成功概率较高(调整RR 1.07,95%CI 1.02-1.12)。
- 按场所分层:急诊科插管中高剂量与标准剂量无显著差异(调整RR 0.97,95%CI 0.89-1.04);ICU插管中高剂量组首次插管成功率较高(调整RR 1.13,95%CI 1.06-1.20)。
证据类型、等级与局限
- 证据类型:两项多中心随机对照试验的二次分析。
- 局限:作者指出可能存在未测量的混杂因素,并认为这些发现需要在随机对照试验中评估。
对床旁实践的改变
- 作者认为,鉴于可能存在未测量的混杂因素,高剂量罗库溴铵(>1.2 mg/kg)与首次插管成功率较高的关联需要在随机对照试验中评估。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: The neuromuscular blockade dose may affect intubation success on the first attempt, thereby impacting outcomes for patients undergoing emergency tracheal intubation.
OBJECTIVES: To evaluate the association between rocuronium dose and tracheal intubation outcomes among adults undergoing emergency tracheal intubation in the emergency department (ED) and intensive care unit (ICU).
METHODS: We conducted a secondary analysis of data from two multicenter randomized controlled trials studying airway management in the ED and ICU. We compared patient characteristics and intubation outcomes between patients receiving high-dose (>1.2 mg/kg) versus standard-dose (≤1.2 mg/kg) rocuronium. The primary outcome was successful intubation on the first attempt. We used propensity matching to account for measured potential confounders, stratified by setting.
MEASUREMENTS AND MAIN RESULTS: Participating sites included 9 EDs and 24 ICUs in the United States. Among 2440 patients in the trial datasets, we included the 1822 (74.7%) patients who received rocuronium in the current analysis. Of these, 720 (39.5%) received high-dose rocuronium, and 1102 (60.5%) received standard-dose rocuronium. Participants receiving high-dose rocuronium had a higher probability of successful intubation on the first attempt (adjusted relative risk [RR] 1.07, 95% confidence interval [CI] 1.02-1.12). This difference in the primary outcome was not present for ED intubations (adjusted RR 0.97, 95% CI 0.89-1.04) but was present for ICU intubations (adjusted RR 1.13, 95% CI 1.06-1.20).
CONCLUSIONS: In this secondary analysis, high-dose rocuronium (>1.2 mg/kg) was associated with higher first-attempt success. Given the potential for unmeasured confounding, these findings warrant evaluation in a randomized controlled trial.
参考来源
- April MD, Butler H, Demasi SC, et al. Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials. Am J Respir Crit Care Med. 2026. PMID: 42149702. doi:10.1093/ajrccm/aamag203
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。